BioMed X
@biomedx.bsky.social
We seed biomedical innovation.
We accelerate the pace of innovation in biomedical research and drug discovery & development by combining the best of both worlds – academia and industry. Our innovation model:
https://pubmed.ncbi.nlm.nih.gov/39235485/
We accelerate the pace of innovation in biomedical research and drug discovery & development by combining the best of both worlds – academia and industry. Our innovation model:
https://pubmed.ncbi.nlm.nih.gov/39235485/
Pinned
BioMed X
@biomedx.bsky.social
· Jun 23
🚀 Applications are now open for our new global #Neuroimmunology research call, supported by Biogen.
📅 Deadline: August 16, 2026
🔗 Learn more & apply: career.bmedx.com/call/2026-NH...
#Neuroimmunology #Neuroscience #Immunology #ResearchOpportunity #BioMedX
📅 Deadline: August 16, 2026
🔗 Learn more & apply: career.bmedx.com/call/2026-NH...
#Neuroimmunology #Neuroscience #Immunology #ResearchOpportunity #BioMedX
🚀 Applications are now open for our new global #Neuroimmunology research call, supported by Biogen.
📅 Deadline: August 16, 2026
🔗 Learn more & apply: career.bmedx.com/call/2026-NH...
#Neuroimmunology #Neuroscience #Immunology #ResearchOpportunity #BioMedX
📅 Deadline: August 16, 2026
🔗 Learn more & apply: career.bmedx.com/call/2026-NH...
#Neuroimmunology #Neuroscience #Immunology #ResearchOpportunity #BioMedX
June 23, 2026 at 12:33 PM
🚀 Applications are now open for our new global #Neuroimmunology research call, supported by Biogen.
📅 Deadline: August 16, 2026
🔗 Learn more & apply: career.bmedx.com/call/2026-NH...
#Neuroimmunology #Neuroscience #Immunology #ResearchOpportunity #BioMedX
📅 Deadline: August 16, 2026
🔗 Learn more & apply: career.bmedx.com/call/2026-NH...
#Neuroimmunology #Neuroscience #Immunology #ResearchOpportunity #BioMedX
📌 12 days left 📌 𝐂𝐚𝐥𝐥 𝐟𝐨𝐫 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧: 𝐀𝐝𝐯𝐚𝐧𝐜𝐢𝐧𝐠 𝐏𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐟𝐨𝐫 𝐄𝐚𝐫𝐥𝐲 𝐃𝐢𝐚𝐛𝐞𝐭𝐢𝐜 𝐊𝐢𝐝𝐧𝐞𝐲 𝐃𝐢𝐬𝐞𝐚𝐬𝐞
This research project is supported by the Government of Barbados and the European Union.
We are looking for your application. For more information, please visit career.bmedx.com/call/2026-BR...
This research project is supported by the Government of Barbados and the European Union.
We are looking for your application. For more information, please visit career.bmedx.com/call/2026-BR...
February 25, 2026 at 9:31 AM
📌 12 days left 📌 𝐂𝐚𝐥𝐥 𝐟𝐨𝐫 𝐀𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧: 𝐀𝐝𝐯𝐚𝐧𝐜𝐢𝐧𝐠 𝐏𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐟𝐨𝐫 𝐄𝐚𝐫𝐥𝐲 𝐃𝐢𝐚𝐛𝐞𝐭𝐢𝐜 𝐊𝐢𝐝𝐧𝐞𝐲 𝐃𝐢𝐬𝐞𝐚𝐬𝐞
This research project is supported by the Government of Barbados and the European Union.
We are looking for your application. For more information, please visit career.bmedx.com/call/2026-BR...
This research project is supported by the Government of Barbados and the European Union.
We are looking for your application. For more information, please visit career.bmedx.com/call/2026-BR...
𝐉𝐨𝐢𝐧 𝐨𝐮𝐫 𝐮𝐩𝐜𝐨𝐦𝐢𝐧𝐠 #InfoSession! 🧬
An online #webinar to learn more about our open Call for Application for a new collaborative research project with AbbVie about: “𝐂𝐢𝐫𝐜𝐮𝐢𝐭-𝐁𝐚𝐬𝐞𝐝 𝐌𝐨𝐝𝐞𝐥 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐨𝐟 𝐀𝐧𝐡𝐞𝐝𝐨𝐧𝐢𝐚.”
Save the date for the exciting #discussion and career #opportunities in neuroscience!
An online #webinar to learn more about our open Call for Application for a new collaborative research project with AbbVie about: “𝐂𝐢𝐫𝐜𝐮𝐢𝐭-𝐁𝐚𝐬𝐞𝐝 𝐌𝐨𝐝𝐞𝐥 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐨𝐟 𝐀𝐧𝐡𝐞𝐝𝐨𝐧𝐢𝐚.”
Save the date for the exciting #discussion and career #opportunities in neuroscience!
December 4, 2025 at 2:31 PM
𝐉𝐨𝐢𝐧 𝐨𝐮𝐫 𝐮𝐩𝐜𝐨𝐦𝐢𝐧𝐠 #InfoSession! 🧬
An online #webinar to learn more about our open Call for Application for a new collaborative research project with AbbVie about: “𝐂𝐢𝐫𝐜𝐮𝐢𝐭-𝐁𝐚𝐬𝐞𝐝 𝐌𝐨𝐝𝐞𝐥 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐨𝐟 𝐀𝐧𝐡𝐞𝐝𝐨𝐧𝐢𝐚.”
Save the date for the exciting #discussion and career #opportunities in neuroscience!
An online #webinar to learn more about our open Call for Application for a new collaborative research project with AbbVie about: “𝐂𝐢𝐫𝐜𝐮𝐢𝐭-𝐁𝐚𝐬𝐞𝐝 𝐌𝐨𝐝𝐞𝐥 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐨𝐟 𝐀𝐧𝐡𝐞𝐝𝐨𝐧𝐢𝐚.”
Save the date for the exciting #discussion and career #opportunities in neuroscience!
📢 Call for Application 📢 Join BioMed X and AbbVie in Advancing Neuroscience Research
We invite you to join our next collaborative research project: “𝐂𝐢𝐫𝐜𝐮𝐢𝐭-𝐁𝐚𝐬𝐞𝐝 𝐌𝐨𝐝𝐞𝐥 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐨𝐟 𝐀𝐧𝐡𝐞𝐝𝐨𝐧𝐢𝐚.”
Discover more about the research project in our Career Space: career.bmedx.com/call/2025-NH...
We invite you to join our next collaborative research project: “𝐂𝐢𝐫𝐜𝐮𝐢𝐭-𝐁𝐚𝐬𝐞𝐝 𝐌𝐨𝐝𝐞𝐥 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐨𝐟 𝐀𝐧𝐡𝐞𝐝𝐨𝐧𝐢𝐚.”
Discover more about the research project in our Career Space: career.bmedx.com/call/2025-NH...
November 25, 2025 at 10:19 AM
📢 Call for Application 📢 Join BioMed X and AbbVie in Advancing Neuroscience Research
We invite you to join our next collaborative research project: “𝐂𝐢𝐫𝐜𝐮𝐢𝐭-𝐁𝐚𝐬𝐞𝐝 𝐌𝐨𝐝𝐞𝐥 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐨𝐟 𝐀𝐧𝐡𝐞𝐝𝐨𝐧𝐢𝐚.”
Discover more about the research project in our Career Space: career.bmedx.com/call/2025-NH...
We invite you to join our next collaborative research project: “𝐂𝐢𝐫𝐜𝐮𝐢𝐭-𝐁𝐚𝐬𝐞𝐝 𝐌𝐨𝐝𝐞𝐥 𝐒𝐲𝐬𝐭𝐞𝐦𝐬 𝐨𝐟 𝐀𝐧𝐡𝐞𝐝𝐨𝐧𝐢𝐚.”
Discover more about the research project in our Career Space: career.bmedx.com/call/2025-NH...
📢 𝐉𝐨𝐢𝐧 𝐨𝐮𝐫 𝐮𝐩𝐜𝐨𝐦𝐢𝐧𝐠 #InfoSession!
BioMed X Institute invites you to a webinar to learn more about the open Call for Applications for the first XFem Labs research project: “𝐍𝐞𝐰 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐟𝐨𝐫 𝐅𝐞𝐦𝐚𝐥𝐞-𝐂𝐨𝐧𝐭𝐫𝐨𝐥𝐥𝐞𝐝 𝐍𝐨𝐧-𝐇𝐨𝐫𝐦𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐭𝐫𝐚𝐜𝐞𝐩𝐭𝐢𝐨𝐧.”
Register now:
us02web.zoom.us/webinar/regi...
BioMed X Institute invites you to a webinar to learn more about the open Call for Applications for the first XFem Labs research project: “𝐍𝐞𝐰 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐟𝐨𝐫 𝐅𝐞𝐦𝐚𝐥𝐞-𝐂𝐨𝐧𝐭𝐫𝐨𝐥𝐥𝐞𝐝 𝐍𝐨𝐧-𝐇𝐨𝐫𝐦𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐭𝐫𝐚𝐜𝐞𝐩𝐭𝐢𝐨𝐧.”
Register now:
us02web.zoom.us/webinar/regi...
November 5, 2025 at 9:14 AM
📢 𝐉𝐨𝐢𝐧 𝐨𝐮𝐫 𝐮𝐩𝐜𝐨𝐦𝐢𝐧𝐠 #InfoSession!
BioMed X Institute invites you to a webinar to learn more about the open Call for Applications for the first XFem Labs research project: “𝐍𝐞𝐰 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐟𝐨𝐫 𝐅𝐞𝐦𝐚𝐥𝐞-𝐂𝐨𝐧𝐭𝐫𝐨𝐥𝐥𝐞𝐝 𝐍𝐨𝐧-𝐇𝐨𝐫𝐦𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐭𝐫𝐚𝐜𝐞𝐩𝐭𝐢𝐨𝐧.”
Register now:
us02web.zoom.us/webinar/regi...
BioMed X Institute invites you to a webinar to learn more about the open Call for Applications for the first XFem Labs research project: “𝐍𝐞𝐰 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐞𝐬 𝐟𝐨𝐫 𝐅𝐞𝐦𝐚𝐥𝐞-𝐂𝐨𝐧𝐭𝐫𝐨𝐥𝐥𝐞𝐝 𝐍𝐨𝐧-𝐇𝐨𝐫𝐦𝐨𝐧𝐚𝐥 𝐂𝐨𝐧𝐭𝐫𝐚𝐜𝐞𝐩𝐭𝐢𝐨𝐧.”
Register now:
us02web.zoom.us/webinar/regi...
🚨 𝗘𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗡𝗲𝘄𝘀: 𝗕𝗶𝗼𝗠𝗲𝗱 𝗫 𝗹𝗮𝘂𝗻𝗰𝗵𝗲𝘀 𝗪𝗼𝗺𝗲𝗻’𝘀 𝗛𝗲𝗮𝗹𝘁𝗵 𝗥&𝗗 𝗔𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗼𝗿 𝗶𝗻 𝗛𝗲𝗶𝗱𝗲𝗹𝗯𝗲𝗿𝗴
The first initiative supported by the Gates Foundation. Discover our first research project here: bmedx.com/news-events/...
Don't miss the chance to shape the #future of women’s health! We're excited about your ideas💡
The first initiative supported by the Gates Foundation. Discover our first research project here: bmedx.com/news-events/...
Don't miss the chance to shape the #future of women’s health! We're excited about your ideas💡
October 15, 2025 at 7:45 AM
🚨 𝗘𝘅𝗰𝗶𝘁𝗶𝗻𝗴 𝗡𝗲𝘄𝘀: 𝗕𝗶𝗼𝗠𝗲𝗱 𝗫 𝗹𝗮𝘂𝗻𝗰𝗵𝗲𝘀 𝗪𝗼𝗺𝗲𝗻’𝘀 𝗛𝗲𝗮𝗹𝘁𝗵 𝗥&𝗗 𝗔𝗰𝗰𝗲𝗹𝗲𝗿𝗮𝘁𝗼𝗿 𝗶𝗻 𝗛𝗲𝗶𝗱𝗲𝗹𝗯𝗲𝗿𝗴
The first initiative supported by the Gates Foundation. Discover our first research project here: bmedx.com/news-events/...
Don't miss the chance to shape the #future of women’s health! We're excited about your ideas💡
The first initiative supported by the Gates Foundation. Discover our first research project here: bmedx.com/news-events/...
Don't miss the chance to shape the #future of women’s health! We're excited about your ideas💡
New Call for Applications! Shaping the future of #women’s #health 🚀
#BioMedX & #GatesFoundation join forces to tackle one of the most pressing challenges in biomedical research: female-controlled, non-hormonal contraception. Submit your proposal via our CareerSpace: career.bmedx.com/call/2025-XF...
#BioMedX & #GatesFoundation join forces to tackle one of the most pressing challenges in biomedical research: female-controlled, non-hormonal contraception. Submit your proposal via our CareerSpace: career.bmedx.com/call/2025-XF...
October 14, 2025 at 7:47 AM
New Call for Applications! Shaping the future of #women’s #health 🚀
#BioMedX & #GatesFoundation join forces to tackle one of the most pressing challenges in biomedical research: female-controlled, non-hormonal contraception. Submit your proposal via our CareerSpace: career.bmedx.com/call/2025-XF...
#BioMedX & #GatesFoundation join forces to tackle one of the most pressing challenges in biomedical research: female-controlled, non-hormonal contraception. Submit your proposal via our CareerSpace: career.bmedx.com/call/2025-XF...
🚨 New episode of #VoicesOfBioMedX! 🎙️
Meet Elizaveta, a Research Assistant from team #TMI at BioMed X, as she shares her motivation to work in an innovative environment where academic research closely connects with translational projects.
Listen to the interview: www.youtube.com/watch?v=ARPz...
Meet Elizaveta, a Research Assistant from team #TMI at BioMed X, as she shares her motivation to work in an innovative environment where academic research closely connects with translational projects.
Listen to the interview: www.youtube.com/watch?v=ARPz...
Day in the life of a Research Assistant | Elizaveta Savochkina | Voices of BiomedX EP 06
YouTube video by BioMed X Institute
www.youtube.com
September 29, 2025 at 10:01 AM
🚨 New episode of #VoicesOfBioMedX! 🎙️
Meet Elizaveta, a Research Assistant from team #TMI at BioMed X, as she shares her motivation to work in an innovative environment where academic research closely connects with translational projects.
Listen to the interview: www.youtube.com/watch?v=ARPz...
Meet Elizaveta, a Research Assistant from team #TMI at BioMed X, as she shares her motivation to work in an innovative environment where academic research closely connects with translational projects.
Listen to the interview: www.youtube.com/watch?v=ARPz...
Join us at @events.embl.org Heidelberg for an inspiring #webinar with Christian Tidona, Founder and Managing Director of BioMed X Institute 🎙
📅 Visit us at EMBL Heidelberg or join 🌐Online via Zoom
🕚 October 10th, 2025 | 11:00 – 12:00 (CEST)
👉 Register here: embl-org.zoom.us/webinar/regi...
📅 Visit us at EMBL Heidelberg or join 🌐Online via Zoom
🕚 October 10th, 2025 | 11:00 – 12:00 (CEST)
👉 Register here: embl-org.zoom.us/webinar/regi...
September 24, 2025 at 3:24 PM
Join us at @events.embl.org Heidelberg for an inspiring #webinar with Christian Tidona, Founder and Managing Director of BioMed X Institute 🎙
📅 Visit us at EMBL Heidelberg or join 🌐Online via Zoom
🕚 October 10th, 2025 | 11:00 – 12:00 (CEST)
👉 Register here: embl-org.zoom.us/webinar/regi...
📅 Visit us at EMBL Heidelberg or join 🌐Online via Zoom
🕚 October 10th, 2025 | 11:00 – 12:00 (CEST)
👉 Register here: embl-org.zoom.us/webinar/regi...
New Call for Application! Reimagining drug delivery 🚀
#BioMedX + #NovoNordisk join forces to tackle one of the toughest challenges in biomedicine: #oral #peptide #formulations. ➡️ Register and apply via our BioMed X Career Space: lnkd.in/e4i3S3Yw
📅 Submit your proposal before #October 12, 2025
#BioMedX + #NovoNordisk join forces to tackle one of the toughest challenges in biomedicine: #oral #peptide #formulations. ➡️ Register and apply via our BioMed X Career Space: lnkd.in/e4i3S3Yw
📅 Submit your proposal before #October 12, 2025
August 19, 2025 at 9:03 AM
New Call for Application! Reimagining drug delivery 🚀
#BioMedX + #NovoNordisk join forces to tackle one of the toughest challenges in biomedicine: #oral #peptide #formulations. ➡️ Register and apply via our BioMed X Career Space: lnkd.in/e4i3S3Yw
📅 Submit your proposal before #October 12, 2025
#BioMedX + #NovoNordisk join forces to tackle one of the toughest challenges in biomedicine: #oral #peptide #formulations. ➡️ Register and apply via our BioMed X Career Space: lnkd.in/e4i3S3Yw
📅 Submit your proposal before #October 12, 2025
🚨 New episode of #VoicesOfBioMedX! 🎙️
Meet Dr. Semih Akincilar, Group Leader at BioMed X, as he explains how targeting DNA damage response (DDR) pathways could transform cancer immunotherapy. 🔬
Learn more about his innovative research to make immune-resistant tumors responsive!
Meet Dr. Semih Akincilar, Group Leader at BioMed X, as he explains how targeting DNA damage response (DDR) pathways could transform cancer immunotherapy. 🔬
Learn more about his innovative research to make immune-resistant tumors responsive!
August 12, 2025 at 10:30 AM
🚨 New episode of #VoicesOfBioMedX! 🎙️
Meet Dr. Semih Akincilar, Group Leader at BioMed X, as he explains how targeting DNA damage response (DDR) pathways could transform cancer immunotherapy. 🔬
Learn more about his innovative research to make immune-resistant tumors responsive!
Meet Dr. Semih Akincilar, Group Leader at BioMed X, as he explains how targeting DNA damage response (DDR) pathways could transform cancer immunotherapy. 🔬
Learn more about his innovative research to make immune-resistant tumors responsive!
💡 New Call for Application: BioMed X & #Servier
are launching the first XSeed Labs research project in Paris-Saclay! Focus: #AI-powered design of #bispecific #antibodies for #cancer #therapy. 🧬 Submit your proposal by August 31 2025: career.bmedx.com/call/2025-XP...
are launching the first XSeed Labs research project in Paris-Saclay! Focus: #AI-powered design of #bispecific #antibodies for #cancer #therapy. 🧬 Submit your proposal by August 31 2025: career.bmedx.com/call/2025-XP...
July 9, 2025 at 2:06 PM
💡 New Call for Application: BioMed X & #Servier
are launching the first XSeed Labs research project in Paris-Saclay! Focus: #AI-powered design of #bispecific #antibodies for #cancer #therapy. 🧬 Submit your proposal by August 31 2025: career.bmedx.com/call/2025-XP...
are launching the first XSeed Labs research project in Paris-Saclay! Focus: #AI-powered design of #bispecific #antibodies for #cancer #therapy. 🧬 Submit your proposal by August 31 2025: career.bmedx.com/call/2025-XP...
Reposted by BioMed X
A day well spent at the 2nd Life Sciences Postdoc Symposium. Thank you to our speakers Christian Tidona @biomedx.bsky.social, Eckhard Thines @unimainz.bsky.social, Marie-Theres Weil #BioNTech & Verawan Boonsanay-Michel #sanofi for their inspiring contributions. And of course to all our participants!
June 27, 2025 at 12:39 PM
A day well spent at the 2nd Life Sciences Postdoc Symposium. Thank you to our speakers Christian Tidona @biomedx.bsky.social, Eckhard Thines @unimainz.bsky.social, Marie-Theres Weil #BioNTech & Verawan Boonsanay-Michel #sanofi for their inspiring contributions. And of course to all our participants!
Info Session on “New Platform for Next-Generation Intraocular Biologics" in partnership with #Boehringer #Ingelheim Call! Available positions for this call include: 1 Group Leader, 2 Postdoctoral Researchers, and 2 Research Assistants
us02web.zoom.us/webinar/regi...
us02web.zoom.us/webinar/regi...
June 12, 2025 at 10:57 AM
Info Session on “New Platform for Next-Generation Intraocular Biologics" in partnership with #Boehringer #Ingelheim Call! Available positions for this call include: 1 Group Leader, 2 Postdoctoral Researchers, and 2 Research Assistants
us02web.zoom.us/webinar/regi...
us02web.zoom.us/webinar/regi...
Are you a U.S.-based academic PI who lost (or may lose) #NIHfunding? 🧠 Apply for #XBridge by @BioMed_X — a new way to continue your research in a fully funded pharma–academia setting in 🇩🇪 Heidelberg or 🇺🇸 New Haven.
🎥 Missed the webinar? Catch the replay now! youtu.be/miqF_wnclOg #biomedicalresearch
🎥 Missed the webinar? Catch the replay now! youtu.be/miqF_wnclOg #biomedicalresearch
June 5, 2025 at 4:06 PM
Are you a U.S.-based academic PI who lost (or may lose) #NIHfunding? 🧠 Apply for #XBridge by @BioMed_X — a new way to continue your research in a fully funded pharma–academia setting in 🇩🇪 Heidelberg or 🇺🇸 New Haven.
🎥 Missed the webinar? Catch the replay now! youtu.be/miqF_wnclOg #biomedicalresearch
🎥 Missed the webinar? Catch the replay now! youtu.be/miqF_wnclOg #biomedicalresearch
Reposted by BioMed X
📢 Don't miss tomorrow's seminar: 'Tracing mitochondrial Dysfunction Signatures in Aging and Autoimmunity', by Dr Gorjana Rackov from the BioMed X Institute, Heidelberg (@biomedx.bsky.social), Germany.
🗓️ 30 May
🕛 12:00
📍 CNB Lecture Hall #CNB_CSIC
🗓️ 30 May
🕛 12:00
📍 CNB Lecture Hall #CNB_CSIC
May 29, 2025 at 2:35 PM
📢 Don't miss tomorrow's seminar: 'Tracing mitochondrial Dysfunction Signatures in Aging and Autoimmunity', by Dr Gorjana Rackov from the BioMed X Institute, Heidelberg (@biomedx.bsky.social), Germany.
🗓️ 30 May
🕛 12:00
📍 CNB Lecture Hall #CNB_CSIC
🗓️ 30 May
🕛 12:00
📍 CNB Lecture Hall #CNB_CSIC
@BioMedXInst & @Boehringer invite researchers to develop next-gen intraocular biologics at #XSeedLabs (CT, USA) to reduce the burden of frequent injections in #retinal disease.
Apply by July 12 👉 career.bmedx.com/call/2025-RD...
#biologics #ophthalmology #pharma
Apply by July 12 👉 career.bmedx.com/call/2025-RD...
#biologics #ophthalmology #pharma
BioMed X Institute
BioMed X Application System
career.bmedx.com
May 22, 2025 at 11:24 AM
@BioMedXInst & @Boehringer invite researchers to develop next-gen intraocular biologics at #XSeedLabs (CT, USA) to reduce the burden of frequent injections in #retinal disease.
Apply by July 12 👉 career.bmedx.com/call/2025-RD...
#biologics #ophthalmology #pharma
Apply by July 12 👉 career.bmedx.com/call/2025-RD...
#biologics #ophthalmology #pharma
We’re launching our first collaboration with Daiichi Sankyo Co., Ltd. on "New Strategies for Targeting Solid Tumors with Multi-Specific Biologics". Boot camp kicks off in Heidelberg—welcome to our partners & participants!
🔗 bmedx.com/news-events/...
🔗 bmedx.com/news-events/...
May 12, 2025 at 4:02 PM
We’re launching our first collaboration with Daiichi Sankyo Co., Ltd. on "New Strategies for Targeting Solid Tumors with Multi-Specific Biologics". Boot camp kicks off in Heidelberg—welcome to our partners & participants!
🔗 bmedx.com/news-events/...
🔗 bmedx.com/news-events/...
🎉Congratulations to our #PTA Team on receiving three 𝐄𝐅𝐈𝐒-𝐄𝐉𝐈 𝐘𝐨𝐮𝐧𝐠 𝐈𝐧𝐯𝐞𝐬𝐭𝐢𝐠𝐚𝐭𝐨𝐫 𝐓𝐫𝐚𝐯𝐞𝐥 𝐀𝐰𝐚𝐫𝐝𝐬 at the 4th #Resolution #Days Meeting in Frankfurt!
May 8, 2025 at 2:32 PM
🎉Congratulations to our #PTA Team on receiving three 𝐄𝐅𝐈𝐒-𝐄𝐉𝐈 𝐘𝐨𝐮𝐧𝐠 𝐈𝐧𝐯𝐞𝐬𝐭𝐢𝐠𝐚𝐭𝐨𝐫 𝐓𝐫𝐚𝐯𝐞𝐥 𝐀𝐰𝐚𝐫𝐝𝐬 at the 4th #Resolution #Days Meeting in Frankfurt!
🌉 Today we launch #XBridge: a unique matchmaking program for U.S. researchers hit by #NIH #funding gaps.
We invite PIs to submit existing NIH proposals to connect with pharma partners via our platform. bio.mx/news/press-r...
Not a grant—an opportunity to keep science moving.
#StandUpForScience 🔬
We invite PIs to submit existing NIH proposals to connect with pharma partners via our platform. bio.mx/news/press-r...
Not a grant—an opportunity to keep science moving.
#StandUpForScience 🔬
April 8, 2025 at 7:57 AM
🌉 Today we launch #XBridge: a unique matchmaking program for U.S. researchers hit by #NIH #funding gaps.
We invite PIs to submit existing NIH proposals to connect with pharma partners via our platform. bio.mx/news/press-r...
Not a grant—an opportunity to keep science moving.
#StandUpForScience 🔬
We invite PIs to submit existing NIH proposals to connect with pharma partners via our platform. bio.mx/news/press-r...
Not a grant—an opportunity to keep science moving.
#StandUpForScience 🔬
We are excited to announce that @johnmlindner.bsky.social , our Head of Immunology Discovery & Head of Research USA, will be introducing T-FINDER at the 6th TCR-Based Therapies Summit in Boston on Wednesday, April 2, 2025.
#precision #immunotherapy. tcr-therapies-summit.com/day-one/?utm...
#precision #immunotherapy. tcr-therapies-summit.com/day-one/?utm...
March 31, 2025 at 11:42 AM
We are excited to announce that @johnmlindner.bsky.social , our Head of Immunology Discovery & Head of Research USA, will be introducing T-FINDER at the 6th TCR-Based Therapies Summit in Boston on Wednesday, April 2, 2025.
#precision #immunotherapy. tcr-therapies-summit.com/day-one/?utm...
#precision #immunotherapy. tcr-therapies-summit.com/day-one/?utm...
🔬 Advancing AI in Drug Development: BioMed X Institute at #ICLR2025 integrating #ComputationalBiology, and #KnowledgeGraphs, and #AgenticAI to transform drug development and clinical translation. Congratulations Team VPE!
March 21, 2025 at 11:08 AM
🔬 Advancing AI in Drug Development: BioMed X Institute at #ICLR2025 integrating #ComputationalBiology, and #KnowledgeGraphs, and #AgenticAI to transform drug development and clinical translation. Congratulations Team VPE!
Our Group Leader, Kyungbo Kim, at 2025 China International Biotechnology Conference in Beijing (April 16-18, 2025)!Novel approach transporting complex macromolecules, even micron-sized bacteria across the intestinal epithelium, by harnessing gut immune cells. nbc2025.eventscribe.net/index.asp?pr...
March 18, 2025 at 10:20 AM
Our Group Leader, Kyungbo Kim, at 2025 China International Biotechnology Conference in Beijing (April 16-18, 2025)!Novel approach transporting complex macromolecules, even micron-sized bacteria across the intestinal epithelium, by harnessing gut immune cells. nbc2025.eventscribe.net/index.asp?pr...
🔬 The Diary of a Scientist: A Webinar Series on Careers in Science 🎙️What does it really take to build a career in science? How do you navigate the transition between academia and industry? Register for free: webinar! us02web.zoom.us/webinar/regi...
March 12, 2025 at 6:27 PM
🔬 The Diary of a Scientist: A Webinar Series on Careers in Science 🎙️What does it really take to build a career in science? How do you navigate the transition between academia and industry? Register for free: webinar! us02web.zoom.us/webinar/regi...
Deadline extended! You have time to submit your proposal until TOMORROW March 11th!
🚨 New Call for Application Alert! 🚨
💡 Project Title: New Strategies for Targeting of Solid Tumors with Multi-Specific Biologics (MTT)
🤝In collaboration with Daiichi Sankyo
🌍Location: Heidelberg
🗓️Apply by: March 9, 2025
📍Innovation Boot Camp: May 12-16, 2025
🔗Apply here: career.bio.mx/call/2025-BM...
💡 Project Title: New Strategies for Targeting of Solid Tumors with Multi-Specific Biologics (MTT)
🤝In collaboration with Daiichi Sankyo
🌍Location: Heidelberg
🗓️Apply by: March 9, 2025
📍Innovation Boot Camp: May 12-16, 2025
🔗Apply here: career.bio.mx/call/2025-BM...
March 10, 2025 at 1:00 PM
Deadline extended! You have time to submit your proposal until TOMORROW March 11th!